Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 20,513,674	$ 25,452,185	$ 23,678,798
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,836,491	3,899,851	3,533,564
(Credit) Provision for bad debts	(978,730)	(614,680)	477,577
Deferred income tax benefit	1,755,520	(4,919,750)	(4,969,669)
Income tax receivable		(1,200,000)
Compensatory element of stock issuances			2,397,276
Stock issued for costs and expenses	$ 1,954,745		$ 2,239,302
Stock option exercised			1,680
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	$ (6,134,095)	$ (4,328,239)	$ (5,899,611)
Notes receivable	(12,689)	(894,665)	11,511
Costs and estimated earnings in excess of Billings on uncompleted contracts	(438,472)	649,423	(736,061)
Inventories	(366,786)	192,882	450,038
Prepaid expenses and other current assets	(79,641)	(1,553)	(513,507)
Other assets	329	15,008	254,721
Increase (decrease) in operating liabilities, net:
Accounts payable	560,977	(122,967)	168,733
Other current liabilities	(980,394)	525,113	(3,660,895)
Customer advances	(59,544)	70,311	(410,855)
Billings in excess of costs and estimated earnings on uncompleted contracts			(206,623)
Other Liabilities	11,943	16,404	8,783
Due to related party medical practices	(134,880)		(17,498)
NET CASH PROVIDED BY OPERATING ACTIVITIES	19,448,448	18,739,323	16,807,264
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(3,355,456)	(2,777,948)	(2,851,158)
Short term investment	(15,094,816)
Cost of acquisition		(58,274)	(1,312,769)
Cost of patents	(128,393)	(108,829)	(155,156)
NET CASH USED IN INVESTING ACTIVITIES	(18,578,665)	(2,945,051)	(4,319,083)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of borrowings and capital lease obligations	(30,725)	(172,484)	(3,990,078)
Repayment of notes receivable from employee stockholders	9,213	7,333	7,333
Distributions to noncontrolling interests	(6,600,000)	(6,135,000)	(6,981,953)
Proceeds received from acquisition -net			87,829
NET CASH USED IN FINANCING ACTIVITIES	(6,621,512)	(6,300,151)	(10,876,869)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(5,751,729)	9,494,121	1,611,312
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	19,633,742	10,139,621	8,528,309
CASH AND CASH EQUIVALENTS - END OF YEAR	$ 13,882,013	$ 19,633,742	$ 10,139,621